ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
TG Therapeutics Inc

TG Therapeutics Inc (TGTX)

21.27
0.08
(0.38%)
Closed July 15 4:00PM
21.27
0.00
( 0.00% )
Pre Market: 4:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
21.27
Bid
20.79
Ask
22.49
Volume
-
0.00 Day's Range 0.00
6.46 52 Week Range 22.67
Market Cap
Previous Close
21.27
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
3,157,476
Shares Outstanding
154,542,945
Dividend Yield
-
PE Ratio
259.39
Earnings Per Share (EPS)
0.08
Revenue
233.66M
Net Profit
12.67M

About TG Therapeutics Inc

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, ... TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a unique epitope on the CD20 antigen found on mature B-lymphocytes. It is also developing TGR-1202 (umbralisib), an orally available PI3K delta inhibitor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
TG Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TGTX. The last closing price for TG Therapeutics was $21.27. Over the last year, TG Therapeutics shares have traded in a share price range of $ 6.46 to $ 22.67.

TG Therapeutics currently has 154,542,945 shares outstanding. The market capitalization of TG Therapeutics is $3.29 billion. TG Therapeutics has a price to earnings ratio (PE ratio) of 259.39.

TG Therapeutics (TGTX) Options Flow Summary

Overall Flow

Bullish

Net Premium

887k

Calls / Puts

100.00%

Buys / Sells

61.54%

OTM / ITM

61.54%

Sweeps Ratio

0.00%

TGTX Latest News

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in...

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in...

TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs for post-marketing studies being undertaken for...

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations highlighting study designs for post-marketing studies...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.68.1342145399119.6722.3419.41303122020.85077428CS
44.5627.28904847416.7122.3416.39284005118.96454806CS
127.150.105857445314.1722.3412.93315747616.94230177CS
265.7737.225806451615.522.3412.84338063616.08746472CS
52-0.83-3.755656108622.122.676.46458717013.72754858CS
156-16.37-43.490967056337.6438.73.48361327414.14238341CS
26013.37169.2405063297.956.743.48283373716.53001471CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDTConduit Pharmaceuticals Inc
$ 0.4682
(95.08%)
18.19M
WNWMeiwu Technology Company Ltd
$ 1.22
(37.08%)
2.1M
SYRASyra Health Corporation
$ 1.75
(31.09%)
1
WINTWindtree Therapeutics Inc
$ 4.50
(21.62%)
5
KYTXKyverna Therapeutics Inc
$ 11.50
(16.04%)
33
GRNQGreenpro Capital Corporation
$ 0.9353
(-20.74%)
79.51k
AMIXAutonomix Medical Inc
$ 1.13
(-18.12%)
390.57k
AREBAmerican Rebel Holdings Inc
$ 0.56
(-16.79%)
134.88k
CYNCYNGN Inc
$ 7.69
(-16.23%)
10.56k
MFImF International Ltd
$ 0.80
(-14.44%)
3.1k
CDTConduit Pharmaceuticals Inc
$ 0.477
(98.75%)
17.94M
KRKR36Kr Holdings Inc
$ 0.3039
(2.25%)
4.06M
SLNASelina Hospitality PLC
$ 0.067
(7.03%)
2.31M
WNWMeiwu Technology Company Ltd
$ 1.23
(38.20%)
2.1M
MAXNMaxeon Solar Technologies Ltd
$ 0.2202
(-3.00%)
1.26M

TGTX Discussion

View Posts
Monksdream Monksdream 6 months ago
TGTX new 52 week high
👍️0
InspectorBullit InspectorBullit 7 months ago
this should have a very good day tomorrow absent a market meltdown. MS drug par excellence.
👍️0
murocman murocman 9 months ago
I would think we’d be close to the bottom here? Almost at a 52 week low!

GLTA,

Murocman
👍️ 1
kld2 kld2 11 months ago
Cheap at these levels. Should see $20 again before long. Friday should be interesting. If script numbers are good, like last Friday, the share price should get a good boost. Half way through Q3. Dumb drop from $21 to $9.
👍️ 1
Max77 Max77 11 months ago
$TGTX CEO Weiss buys 100k shares at 10.13. Now has 12 million shares
👍️ 1
murocman murocman 11 months ago
Barely above pre-approval prices. Unbelievable.

Murocman
👍️ 1
teifhals teifhals 1 year ago
Anyone catch that Genetech is starting to air commercials since they are losing share?
👍️0
Rayn_Makr Rayn_Makr 1 year ago
Great call this morning. Nice run today and just the beginning with Europe coming on soon.
After Hours Time (ET) After Hours Price After Hours Share Volume
17:27:17 $30.5 5,000
$152,500 in one trade. Short covering???
Fun to think about market cap in 2024 and 2025.
👍️0
Alan Brown Alan Brown 1 year ago
Where did you find such news?
👍️0
Aquahoya Aquahoya 1 year ago
Has anyone checked out $GSTC? Similar biotech company like $TGTX except its much newer and has a patented formulation combinational therapy already FDA approved set and waiting for clinical trial approval in India for Multiple Sclerosis. It is an over-the-counter stock sitting over .01 just waiting for clinical trials approval. The market cap is on $8,000,000. The therapy isn't specific to the type of multiple sclerosis. So, the potential here is huge. The conservative market share that was done by seasoned professionals in the space, that is on their presentation is in the BILLIONs. Read the history here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170524593












👍️0
teifhals teifhals 1 year ago
Whens the buyout..?
👍️ 1
Penny chatter Penny chatter 2 years ago
Lol
👍️0
hawkshaw812 hawkshaw812 2 years ago
Looks like tuseday is shorting day .
👍️0
tw0122 tw0122 2 years ago
They have cash and a better MS drug have the price of Roches. Shorts don’t like
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Not only that but they must be...............

On the wrong side of the trade.

When you get squeezed on them nards, it never feels good.


No mercy....... TAKE THEM OUT !!!!!!!


GO $TGTX
👍️0
tw0122 tw0122 2 years ago
Analysts keep on giving it bad sell ratings.
That must be a good sign. Analysts for the most part just share selling scam artists
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Slowllyy creeping up..... now 11.50 in PreMarket

If it can do exactly what $KALA just did by going over $45, I'm a happy camper


GOOOOOOOOOOOooooooooooooooooooooooooooo hardddddddddddddddddddd



GO $TGTX
👍️0
Ringrock Ringrock 2 years ago
Traded@55.70 Jan 8 ‘21… looks like she’s still got quite a bit togo…
👍️0
shamalamadingdong shamalamadingdong 2 years ago
Dosing of first patients in 30 to 45 days from now/going to the market!!
👍️0
TheFinalCD TheFinalCD 2 years ago
$TGTX No offerings on the horizon per CC

$TGTX No offerings on the horizon per CC lfg— Cooway Trades 🐊 ⛪️🚀🇺🇸🙏🏽 (@cooway) December 29, 2022
👍️0
shamalamadingdong shamalamadingdong 2 years ago
Link to 8;30 webcast/conference call.
https://ir.tgtherapeutics.com/events
👍️0
shamalamadingdong shamalamadingdong 2 years ago
Some informative information, pictures of the packaging, disease overview, and more.
https://ml.globenewswire.com/1.0/snippet/1898/eng
👍️0
shamalamadingdong shamalamadingdong 2 years ago
TG Therapeutics Announces FDA Approval Of BRIUMVI; Company To Host Conference Call On Thursday, December 29, 2022 At 8:30 Am ET
👍️0
airman1 airman1 2 years ago
Given a try; on this one in at 8:47 for a morning was jump !!
See if shorts cover before the weekend ??
👍️0
airman1 airman1 2 years ago
Yeah, we may get mm naked! shorts covering tomorrow. Share price may
spike./;)) early GL$$
👍️0
tw0122 tw0122 2 years ago
They have cash and they would let the price go much higher before another offering
👍️0
tw0122 tw0122 2 years ago
$8.73 after hours On a good note company conference 830am and market makers
👍️0
pennyfinder pennyfinder 2 years ago
Probably an offering coming.
👍️0
tw0122 tw0122 2 years ago
Unfortunately lots of illegal naked shorts courtesy of Gary G but see what happens next few days as more shorts cover.
Never a easy game kept a few shares
👍️0
Cheap Stock Investor Cheap Stock Investor 2 years ago
Damn how low is this going? Not headed in right direction at the moment.
👍️0
tw0122 tw0122 2 years ago
MS drug going to make hundreds of millions..

Dec 28 (Reuters) - TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up nearly 9% in afternoon trade.

The approval by the U.S. Food and Drug Administration (FDA) widens the number of such drugs available for treating the disorder to three and may help soften the blow to the company's finances from the withdrawal of its lymphatic cancer drug earlier this year.

TG Therapeutics said it was expecting to launch the drug, branded as Brumvi, in the first quarter of 2023, but did not give details on its pricing.

Jefferies analyst Chris Howerton said ahead of the approval that he was expecting the drug to be priced in the range of $30,000 per patient per year. In comparison, Roche's Ocrevus has a current list price of about $68,000 annually.

Multiple sclerosis is a neurological disease in which the immune system attacks the brain cells causing motor disabilities. It affects about 400,000 people in the United States, according to the National Institutes of Health.

Unlike other MS drugs that target T cells, Brumvi belongs to a class of drugs that tackles B cells' role in driving the inflammation that is central to neurological disease.

The approval, which comes with a warning of infusion reactions from the drug, was based on a late-stage study that showed the drug was effective in reducing the annualized relapse rates in patients. (Reporting by Sriparna Roy, Khushi Mandowara and Raghav Mahobe in Bengaluru; Editing by Anil D'Silva and Shailesh Kuber)
👍️0
SpaceTimeRift777 SpaceTimeRift777 2 years ago
Nice Pump Moon Market
👍️0
tw0122 tw0122 2 years ago
As usual they going to scare folks into
Selling there shares loooks like upper $8s bottom
👍️0
tw0122 tw0122 2 years ago
Still holding about 20% regular short interest and then all the illegal naked Gary G approved ones
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Opens at $11...........


Only the beginning now


GO $TGTX
👍️0
tw0122 tw0122 2 years ago
Can be whatever you want if we see $40s..lol
👍️0
Imarket13 Imarket13 2 years ago
God damn thought you were a woman this whole time
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: I showered.............

Balls, armpits and buttcrack............. good to go.

Took 2mins


GO $TGTX
👍️0
tw0122 tw0122 2 years ago
220pm stand corrected
alfred

@macronewswire
TG THERAPEUTICS (TGTX)TO RESUME TRADING AT 2:20 P.M.
$TGTX
👍️0
Imarket13 Imarket13 2 years ago
I'm hearing within the next hour... everyone wins!!
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Fantastic !!!!!!!!!!!!!


Works for me



GO $TGTX
👍️0
tw0122 tw0122 2 years ago
Halted I believe until 830am
Press release tomorrow. Don’t take my word but pretty sure
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Whats the big deal about PKPH ???

Did they just get an FDA approval like $TGTX ??

GO $TGTX
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: No comment


I hope it doesn't open till tomorrow............. then yer filthy for the next 23hrs



GO $TGTX
👍️0
halbroke1 halbroke1 2 years ago
makin..TGTX nice one, Im In !!.Check out pk*ph.., Real cheap
👍️0
Imarket13 Imarket13 2 years ago
Well they should be. Clean trading is key
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Then go do whatever it is you do..........


TGTX doesn't care if you wanna shower.
Stocks arent concerned about your hygiene.


GO $TGTX
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Remember when TGTX was $55 last year .................


And we didn't have anything like this FIRE news today.


Time to make up for some lost ground, and then some

We'd be at $1 now if it never got approved


GO $TGTX
👍️0
Imarket13 Imarket13 2 years ago
I have to take a shower
Want to see it open first
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: When it wants............



Whats the rush ???


GO $TGTX
👍️0

Your Recent History

Delayed Upgrade Clock